PTU-122A trial with mercaptopurine following azathioprine intolerance is a safe treatment strategy for the majority of patients with IBD

IntroductionAzathioprine intolerance (AZA-I) leads to withdrawal of therapy in up to 30% of patients with IBD. Smaller case series demonstrated that mercaptopurine (MP) could be a well tolerated alternative in selected patients.1 This study aims to further assess its tolerability, in a larger cohort...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gut 2012-07, Vol.61 (Suppl 2), p.A235-A235
Hauptverfasser:	Rhatigan, E B, Kennedy, N A, Arnott, I D, Noble, C L, Shand, A G, Satsangi, J, Lees, C W
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!